Predictive Model for Mortality Risk Stratification Using Laboratory Biomarkers in Singaporeans

Abstract

Current clinical decision-making tools often rely on aggregate scoring systems or subjective assessments, which may not capture early or subtle physiological changes indicating high mortality risk. While laboratory tests are ubiquitously available and inexpensive, their prognostic potential is underutilized.